MedTrace Logo

Impact of Cardiac Surgery With a Minimal Invasive Extracorporeal Circuit οn Coagulation: Data From Point of Care Devices

NCT04159064 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2019-11-13

No results posted yet for this study

Summary

This study includes patients undergoing elective cardiac surgery on MiECC. Coagulation status is assessed with ROTEM (TEM International GmbH, Munich, Germany) and Platelet function with impedance aggregometry using the ROTEM-Platelet (TEM International GmbH, Munich, Germany).

Conditions

  • Extracorporeal Circulation; Complications
  • Coagulation Disorder
  • Extracorporeal Circulation of Blood; Thrombocytopenia

Interventions

DIAGNOSTIC_TEST

Thromboelastometry, Impedance Aggregometry

Study of coagulation changes after cardiac surgery on CPB using Minimal Extracorporeal Circulation

Sponsors & Collaborators

  • AHEPA University Hospital

    lead OTHER

Principal Investigators

  • Kyriakos Anastasiadis, Prof · Director of Cardiothoracic Department, AHEPA University Hospital

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2019-04-30
Completion
2019-04-30
FDA Device
Yes

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04159064 on ClinicalTrials.gov